-
公开(公告)号:US11629172B2
公开(公告)日:2023-04-18
申请号:US16721229
申请日:2019-12-19
Applicant: Pfizer Inc.
Inventor: Philip Ralph Dormitzer , Ye Che , Xiaoyuan Sherry Chi , Seungil Han , Kyle Paul Heim , Thomas Richard Jones , Yuhang Liu , Xiayang Qiu , Xinzhen Yang , Xiaojie Yao , Matthew Curtis Griffor , Jennifer Anne Nicki
IPC: C07K14/005 , A61K39/00
Abstract: The present invention relates to polypeptides and cytomegalovirus (CMV) antigens that include at least one introduced amino acid mutation relative to the amino acid sequence of the wild-type HCMV glycoprotein B (gB). In some embodiments, the polypeptide is stabilized in a conformation alternative to the gB postfusion conformation. Also disclosed are compositions including the polypeptides and uses thereof.
-
公开(公告)号:US20200247853A1
公开(公告)日:2020-08-06
申请号:US16721229
申请日:2019-12-19
Applicant: Pfizer Inc.
Inventor: Philip Ralph Dormitzer , Ye Che , Xiaoyuan Sherry Chi , Seungil Han , Kyle Paul Heim , Thomas Richard Jones , Yuhang Liu , Xiayang Qiu , Xinzhen Yang , Xiaojie Yao , Matthew Curtis Griffor , Jennifer Anne Nicki
IPC: C07K14/005
Abstract: The present invention relates to polypeptides and cytomegalovirus (CMV) antigens that include at least one introduced amino acid mutation relative to the amino acid sequence of the wild-type HCMV glycoprotein B (gB). In some embodiments, the polypeptide is stabilized in a conformation alternative to the gB postfusion conformation. Also disclosed are compositions including the polypeptides and uses thereof.
-
公开(公告)号:US20190127422A1
公开(公告)日:2019-05-02
申请号:US16082177
申请日:2017-03-09
Applicant: Pfizer Inc.
Inventor: Xinzhen Yang , Xiaoyuan Sherry Chi
IPC: C07K14/005 , A61K39/245 , A61P31/20
Abstract: The present invention relates to a polypeptide that includes at least one mutation in the fusion loop 1 region and/or in the fusion loop 2 region and/or in the furin-like cleavage site of a human cytomegalovirus gB polypeptide. In one embodiment, the polypeptide undergoes a structural conformation change in response to pH change.
-
-